Carregant...
The Change From Brand-Name to Generic Aromatase Inhibitors and Hormone Therapy Adherence for Early-Stage Breast Cancer
BACKGROUND: Nonadherence to hormonal therapy is common and is associated with increased copayment amount. We investigated the change in adherence after the introduction of generic aromatase inhibitors (AIs) in 2010. METHODS: Using deidentified pharmacy and claims data from OptumInsight, we identifie...
Guardat en:
| Publicat a: | J Natl Cancer Inst |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4271034/ https://ncbi.nlm.nih.gov/pubmed/25349080 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/dju319 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|